Home/News/News details

Claritin Market Analysis, Manufacturing Cost Structure, Growth Opportunities and Restraint to 2021

May 19, 2017

Claritin Market Analysis, Manufacturing Cost Structure, Growth Opportunities and Restraint to 2021

Claritin is the one of the brand names of Loratadine and is used to treat allergies including urticaria (hives), chronic idiopathic urticaria, Kimura's disease and allergic rhinitis (hay fever). Claritin works well against both the eye and nose symptoms of allergic rhinitis like sneezing, itching or burning of eyes and runny nose. The drug belongs to 2ndgeneration antihistamine family. The drug is also available in combination with pseudoephedrine, a decongestant. The drug is taken by mouth and comes in various forms like tablets, syrups and oral suspension. Claritin was discovered in 1981, came to market in 1993 and is on the World Health Organization's List of Essential Medicines. As of 2015, Claritin is available as an OTC in many countries.

Ask for Sample copy @ https://www.qyresearchgroups.com/request-sample/174785

Common side effects of the drug includes dry mouth, blurred vision, liver problems, gastrointestinal problems, sleepiness, urinary retention, psychomotor retardation allergic reactions, seizures and headache. Sedation is very uncommon. The drug is safe in pregnancy and breast feeding but not recommended in children below 2 years of age.

Contraindications- severe hepatic (liver) disorders, renal disorders of elderly patients

Brands- As of 2017 claritin was available under many brand names, dosage forms and combinations drug formulations with betamethasone, dexamethasone, paracetamol, phenylephrine, ambroxol, salbutamol, pseudoephedrine etc.

Mechanism of action- Claritin is a tricyclic antihistamine and acts by being selective inverse agonist of peripheral histamine H1-receptors.

Pharmacokinetics- Claritin is absorbed well from the gastrointestinal tract and possess rapid first-pass hepatic metabolism; it is metabolized by isoenzymes of the cytochrome P450 system such as CYP2D6, CYP3A4. The drug is almost totally (97–99%) bound to plasma proteins.  The metabolite of Claritin- desloratadine is mainly responsible for the antihistaminergic effects. The peak effect of the drug occurs after 1 to 2 hours after intake and its biological half-life is approximately 8 hours (ranges between 3 to 20 hours). The half life of desloratadine is around 27 hours (ranges between 9 to 92 hours) and is responsible for Claritin’s long lasting effect. About 40% of it is excreted through urine as conjugated metabolites; traces amount can be found in stool.

Interactions- substances like erythromycin, cimetidine, ketoconazole and furanocoumarin derivatives act as inhibitors of the CYP3A4 enzyme can cause increased plasma level of Claritin (loratadine). This is clinically significant in controlled trials.

Precautions- Antihistamines like Claritin should be discontinued about 48 hr before skin allergy tests, since the drugs may prevent or reduce otherwise-positive result of   skin/dermal activity indicators.

Pre Order Enquiry: https://www.qyresearchgroups.com/send-an-enquiry/174785

Table of Contents

Global Claritin Sales Market Report 2016
1 Claritin Overview
1.1 Product Overview and Scope of Claritin
1.2 Classification of Claritin
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Claritin
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Claritin Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Claritin (2011-2021)
1.5.1 Global Claritin Sales and Growth Rate (2011-2021)
1.5.2 Global Claritin Revenue and Growth Rate (2011-2021)

2 Global Claritin Competition by Manufacturers, Type and Application
2.1 Global Claritin Market Competition by Manufacturers
2.1.1 Global Claritin Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Claritin Revenue and Share by Manufacturers (2011-2016)
2.2 Global Claritin (Volume and Value) by Type
2.2.1 Global Claritin Sales and Market Share by Type (2011-2016)
2.2.2 Global Claritin Revenue and Market Share by Type (2011-2016)
2.3 Global Claritin (Volume and Value) by Regions
2.3.1 Global Claritin Sales and Market Share by Regions (2011-2016)
2.3.2 Global Claritin Revenue and Market Share by Regions (2011-2016)
2.4 Global Claritin (Volume) by Application

Read More: https://www.qyresearchgroups.com/report/global-claritin-sales-market-report-2016

8 Claritin Maufacturing Cost Analysis
8.1 Claritin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Process Analysis of Claritin

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Claritin Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Claritin Major Manufacturers in 2015
9.4 Downstream Buyers

Get Discount on this Report @ https://www.qyresearchgroups.com/check-discount/174785

About Us:

QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on global industries, companies, products, and trends.

Contact us:

Email- sales@qyresearchgroups.com

Web- https://www.qyresearchgroups.com

Follow Us:

LinkedIn | Twitter| Facebook

 

footer pattern

All Copyrights reserve worldhealthcarenews.biz 2017.